Translational Development Acqui
Q3 2025 13F Holders
Symbol
TDACU
CUSIP
G9008W121
Type
Equity
Class
UNIT 99/99/9999
Num filings
7
Total reported value, excl. options
$15.8 M
Compare 2025 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type